Le Kremlin-Bicetre, France

Carl Martin

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Dna Script. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carl Martin. Retrieved from https://idiyas.com/inventor/carl-martin-nocu2ds2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Inventor Carl Martin

Introduction

Carl Martin is a notable inventor based in Le Kremlin-Bicêtre, France. He has made significant contributions to the field of enzymatic polynucleotide synthesis. His work focuses on developing systems and apparatus that enhance the efficiency of automated synthesis processes.

Latest Patents

Carl Martin holds a patent for "Systems, apparatus and kits for enzymatic polynucleotide synthesis." This invention is directed towards creating systems that allow for the automated synthesis of multiple polynucleotides within an array of reaction chambers. The process utilizes a template-free polymerase, which is a significant advancement in the field. The invention also includes adaptive elements and processes designed to monitor and control disruptions in the synthesis process caused by enzyme aggregation.

Career Highlights

Carl Martin is currently associated with Dna Script, a company that specializes in innovative solutions for DNA synthesis. His work at Dna Script has positioned him as a key player in the biotechnology sector. His contributions have been instrumental in advancing the capabilities of automated synthesis technologies.

Collaborations

Carl collaborates with talented individuals such as Marc Artigue and Sandrine Creton. Their combined expertise fosters a creative environment that drives innovation in their projects.

Conclusion

Carl Martin's work in enzymatic polynucleotide synthesis represents a significant advancement in biotechnology. His innovative approach and dedication to improving synthesis processes have made a lasting impact in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…